STOCK TITAN

NATIONAL HEALTH INVESTORS (NHI) CEO adds 1,500 shares in open-market buy

(High)
(Positive)
Form Type
4

Rhea-AI Filing Summary

National Health Investors CEO and President D. Eric Mendelsohn bought 1,500 shares of common stock in an open-market purchase at $68.84 per share. After this transaction, he directly owns 133,316 shares, indicating a small increase in his personal stake in the company.

Positive

  • None.

Negative

  • None.
Insider Mendelsohn D. Eric
Role CEO and President
Bought 1,500 shs ($103K)
Type Security Shares Price Value
Purchase Common Stock 1,500 $68.84 $103K
Holdings After Transaction: Common Stock — 133,316 shares (Direct)
Shares purchased 1,500 shares Open-market purchase of common stock
Purchase price $68.84 per share Price paid in open-market transaction
Shares owned after 133,316 shares Direct holdings following transaction
Net buy shares 1,500 shares Net buy direction in transaction summary
open-market purchase financial
"transaction_action: open-market purchase"
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
Common Stock financial
"security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
transaction code P regulatory
"transaction_code: P"
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did NHI CEO D. Eric Mendelsohn report?

D. Eric Mendelsohn reported an open-market purchase of 1,500 shares of NATIONAL HEALTH INVESTORS INC common stock at $68.84 per share. This filing reflects a direct increase in his personal holdings in the company.

How many NHI shares does D. Eric Mendelsohn own after this Form 4?

After the reported transaction, D. Eric Mendelsohn directly owns 133,316 shares of NATIONAL HEALTH INVESTORS INC common stock. This total includes his new 1,500-share open-market purchase disclosed in the Form 4 filing.

Was the NHI insider transaction a purchase or a sale?

The transaction was a purchase. D. Eric Mendelsohn executed an open-market buy of 1,500 shares of NATIONAL HEALTH INVESTORS INC common stock, as indicated by transaction code P and the transaction_direction labeled buy.

What price did the NHI CEO pay per share in the reported transaction?

He paid $68.84 per share. The Form 4 states that 1,500 NATIONAL HEALTH INVESTORS INC common stock shares were acquired in an open-market purchase at a transaction price of $68.84 for each share.

Does the Form 4 for NHI include any derivative transactions?

No derivative transactions are shown in this Form 4. The filing reports only a single non-derivative open-market purchase of 1,500 common stock shares by D. Eric Mendelsohn, with derivativeSummary listed as empty.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mendelsohn D. Eric

(Last)(First)(Middle)
222 ROBERT ROSE DRIVE

(Street)
MURFREESBORO TENNESSEE 37129

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTH INVESTORS INC [ NHI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
CEO and President
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/05/2026P1,500A$68.84133,316D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
/s/ Kimberly V. Ouimet, by limited power of attorney06/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)